The total assets of June 19, 2012 amounted to 1,926,264,400 yuan (including the parent company of 1,558,167,900 yuan), the total liabilities amounted to 617,971,500 yuan (including the parent company, 434,520,200 yuan), and the total stockholders' equity was 130, 8.5049 million yuan (including the parent company 112,391.57 million yuan), attributable to the parent company's owner's equity of 1,263,334,400 yuan, minority shareholders' equity of 4,502.04 million yuan.
During the reporting period, the total profit was RMB 202.6595 million (including the parent company of RMB 20,382.06 million), and the net profit was RMB 178.877 million (including the parent company of RMB 17,275.94), which was attributable to the net profit of the parent company's owner. 17 , 091.10 million yuan, earnings per share of 1.22 yuan, the weighted average return on net assets was 13.82%, the weighted average return on net assets after deducting non-recurring gains and losses was 13.25%. The cash flow generated from operating activities was RMB 81,117,100 (including the parent company of RMB 97,781,100), and the net cash flow from operating activities per share was RMB 0.58 per share (including the parent company of RMB 0.70 per share).
1 In marketing:
The company is committed to maintaining the high-end image of Pien Tze Huang market, to increase brand culture promotion, and strengthen cooperation with mainstream pharmacy chain pharmacies to further enhance the influence of the leading product Pien Tze Huang, and strive to achieve breakthrough growth during the 12th five-year period.
2 In product development:
During the reporting period, the company successfully established an R&D center in Shanghai to increase its independent R&D efforts in pharmaceuticals and cosmetics. In the area of ​​new drug development, we continue to cooperate with the Chinese University of Hong Kong in the expansion of liver fibrosis research in Reversine; collaborate with the Fujian Institute of Microbiology in the development of dermatological treatment drugs; and establish a joint research and development of natural products with Zhangzhou Normal University In cooperation with the room, the development of new products such as Pleurotus eryngii, Agaricus bisporus, Asparagus, and Anoectochilus products was carried out. During the reporting period, the company applied for 10 invention patents and 6 utility model patents and was accepted.
3 In the construction of the internal control system:
The company pays attention to the construction of the internal control standard system. From January 1, 2012, the company organized and implemented the company's business process specification and business approval authority guidelines. The company set up an internal control evaluation team, formulated a self-evaluation work plan, and organized and implemented internal control self-evaluation work. Through self-examination and rectification, the internal control of the company has been further strengthened and standardized, and the enterprise's operation and management level and risk prevention capability have been improved, and the sustainable development of the enterprise has been promoted.
4 According to the overall plan of Quzhou City, the company plans to obtain 1070 mu of land for the construction of Pien Tsz Park by means of a transfer method in Nanjing Hi-tech Industrial Park, and to build a production base for the Pien Tze Huang Estate Industrial Park --- Pienze Tsai series of products and health products. And Pien Tze Huang Estate Industrial Park --- the branch company pharmaceutical production and construction and cultural industries and other projects. The company has already begun to carry out the land acquisition and program design for the construction of the Pien Tsz Pou Industrial Park and is fully prepared for the company to implement the industrial scale economic strategy.
5 The company successively signed contracts with large companies such as China Resources Medicine Group Co., Ltd. and Taiwan Aizhiwei Co., Ltd. to implement joint ventures with brand strategic alliances, and at the same time accelerate its own capital operation to maximize the company's brand effect.
During the reporting period, the total profit was RMB 202.6595 million (including the parent company of RMB 20,382.06 million), and the net profit was RMB 178.877 million (including the parent company of RMB 17,275.94), which was attributable to the net profit of the parent company's owner. 17 , 091.10 million yuan, earnings per share of 1.22 yuan, the weighted average return on net assets was 13.82%, the weighted average return on net assets after deducting non-recurring gains and losses was 13.25%. The cash flow generated from operating activities was RMB 81,117,100 (including the parent company of RMB 97,781,100), and the net cash flow from operating activities per share was RMB 0.58 per share (including the parent company of RMB 0.70 per share).
1 In marketing:
The company is committed to maintaining the high-end image of Pien Tze Huang market, to increase brand culture promotion, and strengthen cooperation with mainstream pharmacy chain pharmacies to further enhance the influence of the leading product Pien Tze Huang, and strive to achieve breakthrough growth during the 12th five-year period.
2 In product development:
During the reporting period, the company successfully established an R&D center in Shanghai to increase its independent R&D efforts in pharmaceuticals and cosmetics. In the area of ​​new drug development, we continue to cooperate with the Chinese University of Hong Kong in the expansion of liver fibrosis research in Reversine; collaborate with the Fujian Institute of Microbiology in the development of dermatological treatment drugs; and establish a joint research and development of natural products with Zhangzhou Normal University In cooperation with the room, the development of new products such as Pleurotus eryngii, Agaricus bisporus, Asparagus, and Anoectochilus products was carried out. During the reporting period, the company applied for 10 invention patents and 6 utility model patents and was accepted.
3 In the construction of the internal control system:
The company pays attention to the construction of the internal control standard system. From January 1, 2012, the company organized and implemented the company's business process specification and business approval authority guidelines. The company set up an internal control evaluation team, formulated a self-evaluation work plan, and organized and implemented internal control self-evaluation work. Through self-examination and rectification, the internal control of the company has been further strengthened and standardized, and the enterprise's operation and management level and risk prevention capability have been improved, and the sustainable development of the enterprise has been promoted.
4 According to the overall plan of Quzhou City, the company plans to obtain 1070 mu of land for the construction of Pien Tsz Park by means of a transfer method in Nanjing Hi-tech Industrial Park, and to build a production base for the Pien Tze Huang Estate Industrial Park --- Pienze Tsai series of products and health products. And Pien Tze Huang Estate Industrial Park --- the branch company pharmaceutical production and construction and cultural industries and other projects. The company has already begun to carry out the land acquisition and program design for the construction of the Pien Tsz Pou Industrial Park and is fully prepared for the company to implement the industrial scale economic strategy.
5 The company successively signed contracts with large companies such as China Resources Medicine Group Co., Ltd. and Taiwan Aizhiwei Co., Ltd. to implement joint ventures with brand strategic alliances, and at the same time accelerate its own capital operation to maximize the company's brand effect.
Plastic Net,Plastic Netting for Garden,Plastic Trellis Net,Plastic Net Fencing
COFCO HEBEI INTERNATIONAL TRADING CO., LTD. , https://www.cofcohb.com